Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 217925
Company: HETERO LABS LTD VI
Company: HETERO LABS LTD VI
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | AP | No | No |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 01/27/2025 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
OXALIPLATIN
INJECTABLE;INTRAVENOUS; 50MG/10ML (5MG/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 207474 | ACCORD HLTHCARE |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078811 | FRESENIUS KABI USA |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 207325 | GLAND |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 217925 | HETERO LABS LTD VI |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078813 | HOSPIRA WORLDWIDE |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 217348 | MEITHEAL |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 091358 | MYLAN LABS LTD |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 204368 | QILU PHARM HAINAN |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078817 | SANDOZ |
| OXALIPLATIN | OXALIPLATIN | 50MG/10ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 219765 | SHANDONG |
INJECTABLE;INTRAVENOUS; 100MG/20ML (5MG/ML)
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 207474 | ACCORD HLTHCARE |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078811 | FRESENIUS KABI USA |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 207325 | GLAND |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 217925 | HETERO LABS LTD VI |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078813 | HOSPIRA WORLDWIDE |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 217348 | MEITHEAL |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 091358 | MYLAN LABS LTD |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 204368 | QILU PHARM HAINAN |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 078817 | SANDOZ |
| OXALIPLATIN | OXALIPLATIN | 100MG/20ML (5MG/ML) | INJECTABLE;INTRAVENOUS | Prescription | No | AP | 219765 | SHANDONG |